A decision is expected in the fourth quarter of 2025.

Cost is a barrier to care for chronic and rare diseases, so financial assistance is way to lower that barrier and help people ...

High costs and the novelty and complexity of new therapies such as gene therapy present social determinants of health and ...

Children and young adults living in states with the biggest drops in Medicaid coverage experienced more prescription ...

A new study by JAMA Health Forum found that universal annual depression screening for young adults during primary care visits ...

In mice with human Merkel cell carcinoma, pyrvinium pamoate significantly reduced tumor growth, potentially offering a new ...

In January 2023, the Brukinsa, a next-generation BTK inhibitor, received FDA approval for chronic lymphocytic leukemia (CLL).

Digital pharmacy solutions can help brick and mortar locations become more efficient, according to Sarah Thomas, VP of sales ...